loading
Inhibrx Biosciences Inc stock is traded at $25.00, with a volume of 223.56K. It is up +3.48% in the last 24 hours and up +9.36% over the past month. Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
See More
Previous Close:
$24.16
Open:
$24.45
24h Volume:
223.56K
Relative Volume:
2.17
Market Cap:
$362.14M
Revenue:
$1.80M
Net Income/Loss:
$1.76B
P/E Ratio:
0.2107
EPS:
118.674
Net Cash Flow:
$-149.23M
1W Performance:
+7.16%
1M Performance:
+9.36%
6M Performance:
+99.04%
1Y Performance:
+92.46%
1-Day Range:
Value
$24.00
$25.61
1-Week Range:
Value
$22.40
$25.61
52-Week Range:
Value
$10.80
$25.61

Inhibrx Biosciences Inc Stock (INBX) Company Profile

Name
Name
Inhibrx Biosciences Inc
Name
Phone
(858) 795-4220
Name
Address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Name
Employee
161
Name
Twitter
Name
Next Earnings Date
2024-05-24
Name
Latest SEC Filings
Name
INBX's Discussions on Twitter

Compare INBX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
INBX
Inhibrx Biosciences Inc
25.00 345.77M 1.80M 1.76B -149.23M 118.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-23-24 Initiated JMP Securities Mkt Perform
Jan-23-24 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Mar-16-22 Initiated SMBC Nikko Outperform
Sep-21-21 Initiated JMP Securities Mkt Outperform
Apr-26-21 Resumed Credit Suisse Outperform
Sep-14-20 Initiated Credit Suisse Outperform
Sep-14-20 Initiated Evercore ISI Outperform
View All

Inhibrx Biosciences Inc Stock (INBX) Latest News

pulisher
Aug 20, 2025

How to monitor Inhibrx Biosciences Inc. with trend dashboardsAnalyst Downgrade & Long-Term Safe Investment Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Momentum Traders Eye Inhibrx Biosciences Inc. for Quick BounceJuly 2025 PreEarnings & Growth Focused Stock Reports - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Inhibrx Biosciences Inc. Recovery Likely Here’s What Data ShowsWeekly Stock Analysis & Long-Term Investment Growth Plans - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Quant Models Detect Momentum Reversal in Inhibrx Biosciences Inc.2025 Growth vs Value & Low Drawdown Investment Strategies - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

Inhibrx Biosciences Inc. stock outlook for YEARMarket Sentiment Report & Weekly Sector Rotation Insights - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Backtesting results for Inhibrx Biosciences Inc. trading strategiesJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to forecast Inhibrx Biosciences Inc. trends using time seriesQuarterly Trade Review & High Win Rate Trade Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Analyzing drawdowns of Inhibrx Biosciences Inc. with statistical tools2025 Dividend Review & Verified Entry Point Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is it too late to sell Inhibrx Biosciences Inc.2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Key resistance and support levels for Inhibrx Biosciences Inc.July 2025 Market Mood & Proven Capital Preservation Methods - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Predicting Inhibrx Biosciences Inc. trend using moving averagesJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-20 02:19:27 - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to build a dashboard for Inhibrx Biosciences Inc. stockQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Inhibrx Biosciences Inc. trending in predictive chart modelsEarnings Overview Summary & Weekly Breakout Stock Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Top chart patterns to watch in Inhibrx Biosciences Inc.Weekly Stock Report & Momentum Based Trading Ideas - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

How to integrate Inhibrx Biosciences Inc. into portfolio analysis tools2025 Stock Rankings & Weekly Watchlist of Top Performers - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

News impact scoring models applied to Inhibrx Biosciences Inc.Portfolio Update Report & Stepwise Trade Signal Guides - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Inhibrx Biosciences Inc. stock prediction for this week2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using flow based indicators on Inhibrx Biosciences Inc.July 2025 WrapUp & Community Trade Idea Sharing Platform - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 05:33:15 - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Short Covering May Lift Inhibrx Biosciences Inc. in Near Term2025 Technical Patterns & Entry Point Strategy Guides - kangso.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Inhibrx Biosciences Inc. Volume Confirms Breakout — Analysts Bullish2025 Year in Review & Weekly High Return Forecasts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Real time breakdown of Inhibrx Biosciences Inc. stock performanceWeekly Gains Summary & Technical Buy Zone Confirmations - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Published on: 2025-08-18 02:46:49 - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Sentiment analysis tools applied to Inhibrx Biosciences Inc.Trade Risk Report & AI Based Buy and Sell Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Reversal indicators forming on Inhibrx Biosciences Inc. stockJuly 2025 Fed Impact & Daily Market Momentum Tracking - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

What’s the recovery path for long term holders of Inhibrx Biosciences Inc.Earnings Overview Summary & AI Enhanced Trade Execution Alerts - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Inhibrx Biosciences Inc. stock trendline breakdown2025 Retail Activity & Verified Entry Point Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Visual trend scoring systems applied to Inhibrx Biosciences Inc.Trade Exit Summary & Safe Capital Growth Tips - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Inhibrx Biosciences (NASDAQ:INBX) Upgraded by Wall Street Zen to Hold Rating - Defense World

Aug 17, 2025
pulisher
Aug 16, 2025

Inhibrx Biosciences Inc. stock trend outlook and recovery path2025 Macro Impact & Low Drawdown Momentum Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will Inhibrx Biosciences Inc. benefit from sector rotation2025 Price Targets & Fast Moving Stock Trade Plans - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Inhibrx Biosciences Inc. stock momentum explainedJuly 2025 Patterns & Weekly Top Stock Performers List - Newser

Aug 16, 2025

Inhibrx Biosciences Inc Stock (INBX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Inhibrx Biosciences Inc Stock (INBX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kayyem Jon Faiz
Director
Nov 20 '24
Buy
14.19
37,500
532,204
69,843
Lappe Mark
Chief Executive Officer
Sep 12 '24
Buy
15.05
26,963
405,793
692,511
Lappe Mark
Chief Executive Officer
Sep 16 '24
Buy
17.13
13,037
223,324
705,548
Vuori Kristiina MD
Director
Sep 11 '24
Buy
15.07
6,457
97,307
13,776
Vuori Kristiina MD
Director
Sep 10 '24
Buy
15.00
179
2,685
7,319
Lappe Mark
Chief Executive Officer
Sep 06 '24
Buy
15.29
26,000
397,540
647,548
Lappe Mark
Chief Executive Officer
Sep 09 '24
Buy
15.21
9,500
144,495
657,048
Lappe Mark
Chief Executive Officer
Sep 10 '24
Buy
15.19
8,500
129,115
665,548
Lappe Mark
Chief Executive Officer
Sep 03 '24
Buy
15.81
20,000
316,263
165,000
Lappe Mark
Chief Executive Officer
Aug 29 '24
Buy
14.03
10,000
140,300
135,000
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):